CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03250273
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:45.451023+00:00
Published At: 2021-12-16T00:00:00+00:00
Record Updated At: 2025-05-28
Results Posted At: 2021-12-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Cholangiocarcinoma", "Cholangiocarcinoma", "Pancreatic Cancer", "Metastatic Pancreatic Cancer", "Unresectable Pancreatic Cancer", "Unresectable Cholangiocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-28"
protocolSection.identificationModule.nctId: "NCT03250273"
protocolSection.identificationModule.officialTitle: "A Phase 2 Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2021-12-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.